Page 2 - Natalie Mount News Today : Breaking News, Live Updates & Top Stories | Vimarsana

May 06 2021 Following progress made by the company over the past 18 months, Adaptate Biotherapeutics (Adaptate), a developer of antibody-based therapeutics for modulation of gamma delta T cells, announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited (Takeda), have together made a further equity investment of $18 million (circa. £13 million).  This funding brings the total raised since Adaptate’s inception in late 2019 to $34 million (circa. £25 million). The funds will be used to accelerate the company’s lead therapeutic anti...

Rinri Therapeutics Appoints Experienced Life Science Executive Nick Higgins as Chairman Extensive private and public company corporate development track record Significant expertise in cell and gene therapy News provided by Share this article Share this article SHEFFIELD, England, Feb. 1, 2021 /PRNewswire/ -- Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, today announces the appointment of Nick Higgins as Chairman of the Board. He takes over from Dr Erica Whittaker who has served as Chair since the creation of Rinri Therapeutics. Nick's ...